After growing up in the Netherlands and Germany, I graduated as a medical doctor in 2014, having tried to spend as much time possible traveling and seeing various different health care systems around the world. This also lead me to end up working in Denmark, where I enjoyed being a clinician for several years, until I was introduced and recruited to CSS. Here I am now allowed to see and participate in a different, yet just as exciting, side of medicine and surgery!
2015-2017: Resident, Department of Surgery, Herlev Hospital
2017-2018: Resident, Department of Obstetrics and Gynecology, Zealand University Hospital Roskilde
2018-2019: Resident, Department of Surgery, Zealand University Hospital Køge
2019-2021: Resident, Department of Surgery, Nordsjællands Hospital Hillerød
2021 – : PhD-student at Center for Surgical Science
2007-2014: Medicine, Ludwig-Maximilians Universität München
2010-2011: ERASMUS semester, Medicine, Université Pierre et Marie Curie, Paris, France
2011-2014: Clinical electives at Tygerberg Hospital (Cape Town, South Africa), Royal North Shore Hospital (Sydney, Australia), Vivantes Klinikum Friedrichshain (Berlin, Germany), The Royal Infirmary (Edinburgh, Scotland), Klinik Dr. Geisenhofer (Munich, Germany)
My research centers around inflammatory bowel disease (IBD) and surgery. I am currently preparing a clinical trial that focuses on patients with pouchitis, and helping to set up an IBD surgery database at Zealand University Hospital. This database will focus on identifying factors that influence the perioperative course of IBD patients, and will be a potential basis for future clinical trials. Furthermore, I am involved with the Big Data team from CSS, and helping to implement data from Danish Health registries into the OMOP Common Data model. While this currently focuses mainly on cancer-based research, I am aiming to utilize this work for building an IBD CDM that can be used for identifying risk factors and create prediction models in order to develop personalized medicine for patients with IBD.
- Teresa Kauke, Cornelia Oberhauser, Viviane Lin, Michaela Coenen, Michael Fischereder, Andrea Dick, Ulf Schoenermarck, Markus Guba, Joachim Andrassy, Jens Werner, Bruno Meiser, Martin Angele, Manfred Stangl, Antje Habicht De novo donor-specific anti-HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q-binding ability. Transpl Int. 2017 Apr;30(4):360-370. doi: 10.1111/tri.12887. Epub 2017 Feb 16
LAST UPDATE: MAY 2021